Program Committee

Adam Aten, MPH, MSc 
Policy Research Associate         
Duke-Margolis Center for Health Policy, Bethesda, MD, USA

 

Marc Berger, MD       
Consultant and Scientific Advisor; Retired, New York, NY, USA

Gracy Crane, PhD       
Regulatory Policy Lead, Roche, Welwyn, England, UK

William Crown, PhD    
Distinguished Research Scientist, Brandeis University, Waltham, MA, USA

 

Nancy Dreyer, MPH, PhD    
Chief Scientific Officer Emerita, Dreyer Strategies LLC, Newton, MA, USA

 

Wim Goettsch, PhD    
Special Advisor HTA, Zorginstituut Nederland, Dieman, Netherlands

 

Jennifer Graff, PharmD 
Senior Director, Professional Affairs, AMCP, Kensington, MD, USA

 

Rachele Hendricks Sturrup, DHSc, MSc, MA     
Research Director, RWE, Duke-Margolis Center for Health Policy, Washington, DC, USA

 

Pall Jonsson, BSc, PhD  
Programme Director - Data, National Institute for Health and Care Excellence, Manchester, England, UK

 

Christina Mack, MSPH, PhD     
Vice President, Epidemiology, IQVIA, Chapel Hill, NC, USA

 

Daniel Mullins, PhD    
Professor, University of Maryland Baltimore, Baltimore, MD, USA

 

Lucinda Orsini, MPH    
Vice President, Value and Outcomes Research, COMPASS Pathways, Skillman, NJ, USA

 

Anton Pottegård, PhD, DMSc   
Professor, University of Southern Denmark, Odense, Denmark

 

Sebastian Schneeweiss, ScD, MD        
Professor of Medicine and Epidemiology at Harvard Medical School and Chief of the Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA

 

Massoud Toussi, MBA, MSc, PhD, MD  
Global Category Lead, RWE, IQVIA, Courbevoie, France

 

David Van Brunt, PhD  
Head of Real-World Data Science, Astellas, Libertyville, IL, USA